Key Takeaways
- •Sermorelin is the shortest fragment of growth hormone-releasing hormone that still fully activates its receptor: residues 1 to 29 of the natural 44-residue peptide, with an amidated C-terminus.
- •It is a full agonist at the GHRH receptor despite the truncation, so the missing 15 residues are not required for activation.
- •The GHRH receptor is a class B (secretin family) G-protein-coupled receptor, the family whose peptide ligands are recognised by a large extracellular N-terminal domain.
- •The signalling route is conventional: receptor binds, Gas activates adenylyl cyclase, cyclic AMP rises, protein kinase A phosphorylates its targets.
- •Downstream, cation-channel opening depolarises the membrane, voltage-gated calcium channels open and calcium entry drives exocytosis of stored hormone.
- •Sermorelin is not the same molecule as [Nle27]GHRH(1-29)NH2, a substituted analogue that appears in the same literature. Check which molecule a paper used.
Summary
Sermorelin is growth hormone-releasing hormone cut down to its first 29 amino acids, with the cut end amidated. The natural hormone is 44 residues long, and the point of the fragment is that it still activates the receptor fully, so the other fifteen residues are not doing the activating.
The mechanism is a standard class B G-protein cascade. Sermorelin holds the GHRH receptor in its active conformation, Gas switches on adenylyl cyclase, cyclic AMP rises and protein kinase A phosphorylates its substrates. The membrane depolarises and voltage-gated calcium channels open, and calcium entering the cell is what triggers exocytosis of hormone already stored in secretory granules.
The signalling description below comes from cell work on pituitary-derived cells and from receptor reviews. It describes a mechanism at the receptor and cell level and nothing more.
What Sermorelin Is
Natural growth hormone-releasing hormone contains 44 amino acids. Sermorelin includes just the first 29 amino acids, with an amidated C-terminus that aids molecular stability. The 29-residue amidated fragment was characterised as a functional GHRH analogue in the 1980s.(1)
Sermorelin Structure Basics
Natural growth hormone-releasing hormone signals primarily to the growth hormone-producing cells of the anterior pituitary, the somatotrophs, which express the GHRH receptor. Even with its shorter chain, sermorelin fully activates that receptor in cell-based systems. The N-terminal region carries the activation determinants, which is why truncation at residue 29 preserves agonism.
Researchers use Peptide Glossary resources to clarify terms like these. C-terminal amidation removes a free carboxylate and protects the end of the chain from carboxypeptidase cleavage.
Being a 29-residue chain with an amidated C-terminus, sermorelin's identity on a certificate rests on mass plus a fragment series rather than mass alone; see what proves a sequence.
Activation in Pituitary Cell Systems
Sermorelin binds the extracellular domain of the GHRH receptor in pituitary-derived cells. This binding stabilises an active receptor conformation that couples to Gas proteins. Halmos et al. describe Gas as the membrane-bound switch relaying the signal to intracellular enzymes.(2) Culhane et al. review how class B receptors transduce peptide hormone binding across the membrane.(4)
Gas activation stimulates adenylyl cyclase, raising cyclic AMP. Cyclic AMP acts as a second messenger, and protein kinase A receives that input, phosphorylating its target proteins.
Calcium and Exocytosis
In capacitance measurements on human GH-secreting adenoma cells, Takei et al. examined how calcium and cyclic AMP each contribute to hormone exocytosis.(3) Receptor stimulation opens nonselective cation channels and depolarises the membrane. That favours voltage-gated Ca²⁺ channel opening, and Ca²⁺ entry triggers exocytosis.
Cyclic AMP acts alongside this calcium-dependent release. The two signals together are what couple receptor occupancy to secretion in these cells. Visit Free peptide tools for calculators used in peptide work.
What These Studies Add Up To
The cell-level picture is a complete and conventional one: a class B GPCR, Gs coupling, cyclic AMP and protein kinase A, membrane depolarisation and calcium-triggered exocytosis. Two cautions travel with it. The capacitance work used adenoma cells rather than normal somatotrophs, and the clinical literature on GHRH fragments mixes sermorelin with substituted analogues such as [Nle27]GHRH(1-29)NH2, so the molecule has to be checked paper by paper.
Sermorelin is supplied for laboratory research only, to qualified researchers and licensed laboratories, and is not for human consumption.
References
- Clark RG, Robinson IC. Nature. 1985 Mar 21-27;314(6008):281-3. PMID: 2858818. https://doi.org/10.1038/314281a0
- Halmos G, Szabo Z, Dobos N, Juhasz E, Schally AV. Growth hormone-releasing hormone receptor (GHRH-R) and its signaling. Rev Endocr Metab Disord. 2025 Jun;26(3):343-352. doi: 10.1007/s11154-025-09952-x. Epub 2025 Feb 12. PMID: 39934495; PMCID: PMC12137518.
- Takei T, Yasufuku-Takano J, Takano K, Fujita T, Yamashita N. Effect of Ca2+ and cAMP on capacitance-measured hormone secretion in human GH-secreting adenoma cells. Am J Physiol. 1998 Oct;275(4):E649-54. doi: 10.1152/ajpendo.1998.275.4.E649. PMID: 9755084.
- Culhane KJ, Liu Y, Cai Y, Yan EC. Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors. Front Pharmacol. 2015;6:264. doi: 10.3389/fphar.2015.00264. PMID: 26594176.
Related Research Compounds
Every compound below is held to a >99% HPLC purity specification, which is a release threshold rather than a measurement. Published certificates for specific lots are listed on the certificates page, and a certificate for any other batch is available on request.
| Compound | Purity specification | Size |
|---|---|---|
| Sermorelin 5mg | >99% | 5mg |
| HCG 5,000iu | >99% | 5,000iu |
